Ye Ming, Vena Jennifer E, Shen-Tu Grace, Johnson Jeffrey A, Eurich Dean T
School of Public Health, University of Alberta, Edmonton, AB T6G 2G4, Canada.
Alberta's Tomorrow Project, Cancer Care Alberta, Alberta Health Services, Calgary, AB T2T 5C7, Canada.
Healthcare (Basel). 2024 Oct 8;12(19):2009. doi: 10.3390/healthcare12192009.
The objective is to characterize the impact of COVID-19 on major healthcare for diabetes, including hospitalization, emergency department (ED) visits and primary care visits in Alberta, Canada.
Participants from Alberta's Tomorrow Project (ATP) with pre-existing diabetes prior to 1 April 2018 were included and followed up to 31 March 2021. A time-segmented regression model was used to characterize the impact of COVID-19 on healthcare utilization after adjusting for seasonality, socio-demographic factors, lifestyle behaviors and comorbidity profile of patients.
Among 6099 participants (53.5% females, age at diagnosis 56.1 ± 9.9 y), the overall rate of hospitalization, ED visits and primary care visits was 151.5, 525.9 and 8826.9 per 1000 person-year during the COVID-19 pandemic (up to 31 March 2021), which means they reduced by 12% and 22% and increased by 6%, compared to pre-pandemic rates, respectively. Specifically, the first COVID-19 state of emergency (first wave of the outbreak) was associated with reduced rates of hospitalization, ED visits and primary care visits, by 79.4% (95% CI: 61.3-89.0%), 93.2% (95% CI: 74.6-98.2%) and 65.7% (95% CI: 47.3-77.7%), respectively. During the second state of emergency, healthcare utilization continued to decrease; however, a rebound (increase) of ED visits was observed during the period when the public health state of emergency was relaxed.
The declared COVID-19 states of emergency had a negative impact on healthcare utilization for people with diabetes, especially for hospital and ED services, which suggests the importance of enhancing the capacity of these two healthcare sectors during future COVID-19-like public health emergencies.
本研究旨在描述2019冠状病毒病(COVID-19)对加拿大艾伯塔省糖尿病患者主要医疗保健的影响,包括住院治疗、急诊科就诊和初级保健就诊情况。
纳入2018年4月1日前已患有糖尿病的艾伯塔省明日项目(ATP)参与者,并随访至2021年3月31日。采用时间分段回归模型,在调整了季节性、社会人口学因素、生活方式行为和患者合并症情况后,描述COVID-19对医疗保健利用的影响。
在6099名参与者中(53.5%为女性,诊断时年龄为56.1±9.9岁),在COVID-19大流行期间(截至2021年3月31日),住院、急诊科就诊和初级保健就诊的总体发生率分别为每1000人年151.5次、525.9次和8826.9次,与大流行前相比,分别下降了12%、22%,增加了6%。具体而言,首次COVID-19紧急状态(疫情第一波)与住院、急诊科就诊和初级保健就诊率下降相关,分别下降了79.4%(95%置信区间:61.3-89.0%)、93.2%(95%置信区间:74.6-98.2%)和65.7%(95%置信区间:47.3-77.7%)。在第二次紧急状态期间,医疗保健利用率持续下降;然而,在公共卫生紧急状态放松期间,观察到急诊科就诊出现反弹(增加)。
宣布的COVID-19紧急状态对糖尿病患者的医疗保健利用产生了负面影响,尤其是对医院和急诊科服务,这表明在未来类似COVID-19的公共卫生紧急情况期间,加强这两个医疗部门的能力非常重要。